Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kelly, DL; Nelson, MW; Love, RC; Yu, Y; Conley, RR
   Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine
   PSYCHIATRIC SERVICES
   
   D.L. Kelly et al., "Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine", PSYCH SERV, 52(5), 2001, pp. 676-678
2. Kelly, DL; Nelson, MW; Love, RC; Yu, Y; Conley, RR
   Conclusions about risperidone - Reply
   PSYCHIATRIC SERVICES
   
   D.L. Kelly et al., "Conclusions about risperidone - Reply", PSYCH SERV, 52(11), 2001, pp. 1535-1535
3. Conley, RR
   Evaluating clinical trial data: Outcome measures
   JOURNAL OF CLINICAL PSYCHIATRY
   
   R.R. Conley, "Evaluating clinical trial data: Outcome measures", J CLIN PSY, 62, 2001, pp. 23-28
4. Avila, MT; Conley, RR; Carpenter, WT
   A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research
   BIOLOGICAL PSYCHIATRY
   
   M.T. Avila et al., "A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research", BIOL PSYCHI, 50(7), 2001, pp. 479-486
5. Richardson, C; Kelly, DL; Conley, RR
   Biperiden for excessive sweating from clozapine
   AMERICAN JOURNAL OF PSYCHIATRY
   
   C. Richardson et al., "Biperiden for excessive sweating from clozapine", AM J PSYCHI, 158(8), 2001, pp. 1329-1330
6. Conley, RR; Mahmoud, R
   A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder
   AMERICAN JOURNAL OF PSYCHIATRY
   
   R.R. Conley e R. Mahmoud, "A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder", AM J PSYCHI, 158(5), 2001, pp. 765-774
7. Conley, RR; Mahmoud, R
   A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder (vol 158, pg 765, 2001)
   AMERICAN JOURNAL OF PSYCHIATRY
   
   R.R. Conley e R. Mahmoud, "A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder (vol 158, pg 765, 2001)", AM J PSYCHI, 158(10), 2001, pp. 1759-1759
8. Conley, RR
   Risperidone side effects
   JOURNAL OF CLINICAL PSYCHIATRY
   
   R.R. Conley, "Risperidone side effects", J CLIN PSY, 61, 2000, pp. 20-23
9. Conley, RR; Meltzer, HY
   Adverse events related to olanzapine
   JOURNAL OF CLINICAL PSYCHIATRY
   
   R.R. Conley e H.Y. Meltzer, "Adverse events related to olanzapine", J CLIN PSY, 61, 2000, pp. 26-29
10. Carpenter, WT; Gold, JM; Lahti, AC; Queern, CA; Conley, RR; Bartko, JJ; Kovnick, J; Appelbaum, PS
    Decisional capacity for informed consent in schizophrenia research
    ARCHIVES OF GENERAL PSYCHIATRY
    
    W.T. Carpenter et al., "Decisional capacity for informed consent in schizophrenia research", ARCH G PSYC, 57(6), 2000, pp. 533-538
11. Gao, XM; Sakai, K; Roberts, RC; Conley, RR; Dean, B; Tamminga, CA
    Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: Effects of schizophrenia
    AMERICAN JOURNAL OF PSYCHIATRY
    
    X.M. Gao et al., "Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: Effects of schizophrenia", AM J PSYCHI, 157(7), 2000, pp. 1141-1149
12. Kelly, DL; Conley, RR; Tamminga, CA
    Differential olanzapine plasma concentrations by sex in a fixed-dose study
    SCHIZOPHRENIA RESEARCH
    
    D.L. Kelly et al., "Differential olanzapine plasma concentrations by sex in a fixed-dose study", SCHIZOPHR R, 40(2), 1999, pp. 101-104
13. Carpenter, WT; Conley, RR
    Sense and nonsense: an essay on schizophrenia research ethics
    SCHIZOPHRENIA RESEARCH
    
    W.T. Carpenter e R.R. Conley, "Sense and nonsense: an essay on schizophrenia research ethics", SCHIZOPHR R, 35(3), 1999, pp. 219-225
14. Love, RC; Conley, RR; Kelly, DL; Bartko, JJ
    A dose-outcome analysis of risperidone
    JOURNAL OF CLINICAL PSYCHIATRY
    
    R.C. Love et al., "A dose-outcome analysis of risperidone", J CLIN PSY, 60(11), 1999, pp. 771-775
15. Conley, RR; Tamminga, CA; Kelly, DL; Richardson, CM
    Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response
    BIOLOGICAL PSYCHIATRY
    
    R.R. Conley et al., "Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response", BIOL PSYCHI, 46(1), 1999, pp. 73-77
16. Conley, RR; Love, RC; Kelly, DL; Bartko, JJ
    Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine
    AMERICAN JOURNAL OF PSYCHIATRY
    
    R.R. Conley et al., "Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine", AM J PSYCHI, 156(6), 1999, pp. 863-868
17. Pandey, GN; Dwivedi, Y; Pandey, SC; Teas, SS; Conley, RR; Roberts, RC; Tamminga, CA
    Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta(1) protein in the prefrontal cortex of teenage suicide subjects
    AMERICAN JOURNAL OF PSYCHIATRY
    
    G.N. Pandey et al., "Low phosphoinositide-specific phospholipase C activity and expression of phospholipase C beta(1) protein in the prefrontal cortex of teenage suicide subjects", AM J PSYCHI, 156(12), 1999, pp. 1895-1901
18. LAHTI RA; ROBERTS RC; COCHRANE EV; PRIMUS RJ; GALLAGER DW; CONLEY RR; TAMMINGA CA
    DIRECT DETERMINATION OF DOPAMINE D-4 RECEPTORS IN NORMAL AND SCHIZOPHRENIC POSTMORTEM BRAIN-TISSUE - A [H-3]NGD-94-1 STUDY
    Molecular psychiatry
    
    R.A. Lahti et al., "DIRECT DETERMINATION OF DOPAMINE D-4 RECEPTORS IN NORMAL AND SCHIZOPHRENIC POSTMORTEM BRAIN-TISSUE - A [H-3]NGD-94-1 STUDY", Molecular psychiatry, 3(6), 1998, pp. 528-533
19. Moore, DB; Kelly, DL; Sherr, JD; Love, RC; Conley, RR
    Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: Comparison with risperidone
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    
    D.B. Moore et al., "Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: Comparison with risperidone", AM J HEAL S, 55, 1998, pp. S17-S19
20. Kelly, DL; Conley, RR; Love, RC; Horn, DS; Ushchak, CM
    Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
    
    D.L. Kelly et al., "Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months", J CH AD PSY, 8(3), 1998, pp. 151-159
21. CONLEY RR; KELLY DL; GALE EA
    OLANZAPINE RESPONSE IN TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS WITH A HISTORY OF SUBSTANCE-ABUSE
    Schizophrenia research
    
    R.R. Conley et al., "OLANZAPINE RESPONSE IN TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS WITH A HISTORY OF SUBSTANCE-ABUSE", Schizophrenia research, 33(1-2), 1998, pp. 95-101
22. LAHTI RA; COCHRANE EV; ROBERTS RC; CONLEY RR; TAMMINGA CA
    [H-3]NEUROTENSIN RECEPTOR DENSITIES IN HUMAN POSTMORTEM BRAIN-TISSUE OBTAINED FROM NORMAL AND SCHIZOPHRENIC PERSONS - AN AUTORADIOGRAPHIC STUDY
    Journal of neural transmission
    
    R.A. Lahti et al., "[H-3]NEUROTENSIN RECEPTOR DENSITIES IN HUMAN POSTMORTEM BRAIN-TISSUE OBTAINED FROM NORMAL AND SCHIZOPHRENIC PERSONS - AN AUTORADIOGRAPHIC STUDY", Journal of neural transmission, 105(4-5), 1998, pp. 507-516
23. CONLEY RR
    OPTIMIZING TREATMENT WITH CLOZAPINE
    The Journal of clinical psychiatry
    
    R.R. Conley, "OPTIMIZING TREATMENT WITH CLOZAPINE", The Journal of clinical psychiatry, 59, 1998, pp. 44-48
24. CONLEY RR; TAMMINGA CA; BARTKO JJ; RICHARDSON C; PESZKE M; LINGLE J; HEGERTY J; LOVE R; GOUNARIS C; ZAREMBA S
    OLANZAPINE COMPARED WITH CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
    The American journal of psychiatry
    
    R.R. Conley et al., "OLANZAPINE COMPARED WITH CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA", The American journal of psychiatry, 155(7), 1998, pp. 914-920
25. Carpenter, WT; Conley, RR; Buchanan, RW
    Schizophrenia
    PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
    
    W.T. Carpenter et al., "Schizophrenia", PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, 1998, pp. 27-51
26. CONLEY RR; TAMMINGA CA; BEASLEY C
    OLANZAPINE VS CHLORPROMAZINE IN THERAPY-REFRACTORY SCHIZOPHRENIA
    Schizophrenia research
    
    R.R. Conley et al., "OLANZAPINE VS CHLORPROMAZINE IN THERAPY-REFRACTORY SCHIZOPHRENIA", Schizophrenia research, 24(1-2), 1997, pp. 190-190
27. CONLEY RR; ZAREMBA S; MCMULLEN R; LOVE R
    EVALUATING ABILITY TO CONSENT IN PSYCHOTIC INPATIENTS
    Schizophrenia research
    
    R.R. Conley et al., "EVALUATING ABILITY TO CONSENT IN PSYCHOTIC INPATIENTS", Schizophrenia research, 24(1-2), 1997, pp. 206-206
28. CONLEY RR; BUCHANAN RW
    EVALUATION OF TREATMENT-RESISTANT SCHIZOPHRENIA
    Schizophrenia bulletin
    
    R.R. Conley e R.W. Buchanan, "EVALUATION OF TREATMENT-RESISTANT SCHIZOPHRENIA", Schizophrenia bulletin, 23(4), 1997, pp. 663-674
29. PANDEY GN; DWIVEDI Y; PANDEY SC; CONLEY RR; ROBERTS RC; TAMMINGA CA
    PROTEIN-KINASE-C IN THE POSTMORTEM BRAIN OF TEENAGE SUICIDE VICTIMS
    Neuroscience letters
    
    G.N. Pandey et al., "PROTEIN-KINASE-C IN THE POSTMORTEM BRAIN OF TEENAGE SUICIDE VICTIMS", Neuroscience letters, 228(2), 1997, pp. 111-114
30. DECKELMAN MC; DIXON LB; CONLEY RR
    COMORBID BULIMIA-NERVOSA AND SCHIZOPHRENIA
    The International journal of eating disorders
    
    M.C. Deckelman et al., "COMORBID BULIMIA-NERVOSA AND SCHIZOPHRENIA", The International journal of eating disorders, 22(1), 1997, pp. 101-105
31. PANDEY GN; CONLEY RR; PANDEY SC; GOEL S; ROBERTS RC; TAMMINGA CA; CHUTE D; SMIALEK J
    BENZODIAZEPINE RECEPTORS IN THE POSTMORTEM BRAIN OF SUICIDE VICTIMS AND SCHIZOPHRENIC SUBJECTS
    Psychiatry research
    
    G.N. Pandey et al., "BENZODIAZEPINE RECEPTORS IN THE POSTMORTEM BRAIN OF SUICIDE VICTIMS AND SCHIZOPHRENIC SUBJECTS", Psychiatry research, 71(3), 1997, pp. 137-149
32. TAMMINGA CA; CONLEY RR
    THE APPLICATION OF NEUROIMAGING TECHNIQUES TO DRUG DEVELOPMENT
    The Journal of clinical psychiatry
    
    C.A. Tamminga e R.R. Conley, "THE APPLICATION OF NEUROIMAGING TECHNIQUES TO DRUG DEVELOPMENT", The Journal of clinical psychiatry, 58, 1997, pp. 3-6
33. CONLEY RR; TAMMINGA CA
    OLANZAPINE VS. CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
    Psychopharmacology bulletin
    
    R.R. Conley e C.A. Tamminga, "OLANZAPINE VS. CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA", Psychopharmacology bulletin, 33(3), 1997, pp. 471-471
34. CONLEY RR; TAMMINGA CA; BEASLEY C
    OLANZAPINE VS CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA
    Biological psychiatry
    
    R.R. Conley et al., "OLANZAPINE VS CHLORPROMAZINE IN TREATMENT-RESISTANT SCHIZOPHRENIA", Biological psychiatry, 41, 1997, pp. 246-246
35. CONLEY RR; CARPENTER WT; TAMMINGA CA
    TIME TO CLOZAPINE RESPONSE IN A STANDARDIZED TRIAL
    The American journal of psychiatry
    
    R.R. Conley et al., "TIME TO CLOZAPINE RESPONSE IN A STANDARDIZED TRIAL", The American journal of psychiatry, 154(9), 1997, pp. 1243-1247
36. LAHTI RA; ROBERTS RC; CONLEY RR; COCHRANE EV; MUTIN A; TAMMINGA CA
    D-2-TYPE DOPAMINE-RECEPTORS IN POSTMORTEM HUMAN BRAIN SECTIONS FROM NORMAL AND SCHIZOPHRENIC SUBJECTS
    NeuroReport
    
    R.A. Lahti et al., "D-2-TYPE DOPAMINE-RECEPTORS IN POSTMORTEM HUMAN BRAIN SECTIONS FROM NORMAL AND SCHIZOPHRENIC SUBJECTS", NeuroReport, 7(12), 1996, pp. 1945-1948
37. LAHTI RA; ROBERTS RC; CONLEY RR; TAMMINGA CA
    DOPAMINE D-2, D-3, D-4 RECEPTORS IN HUMAN POSTMORTEM BRAIN SECTIONS -COMPARISON BETWEEN NORMALS AND SCHIZOPHRENICS
    Schizophrenia research
    
    R.A. Lahti et al., "DOPAMINE D-2, D-3, D-4 RECEPTORS IN HUMAN POSTMORTEM BRAIN SECTIONS -COMPARISON BETWEEN NORMALS AND SCHIZOPHRENICS", Schizophrenia research, 18(2-3), 1996, pp. 1-1
38. CONLEY RR; LOVE R
    EVALUATING ABILITY TO CONSENT IN PSYCHOTIC INPATIENTS
    Psychopharmacology bulletin
    
    R.R. Conley e R. Love, "EVALUATING ABILITY TO CONSENT IN PSYCHOTIC INPATIENTS", Psychopharmacology bulletin, 32(3), 1996, pp. 392-392
39. CARPENTER WT; CONLEY RR; BUCHANAN RW; BREIER A; TAMMINGA CA
    CLOZAPINE CONFLICT
    The American journal of psychiatry
    
    W.T. Carpenter et al., "CLOZAPINE CONFLICT", The American journal of psychiatry, 153(11), 1996, pp. 1505-1507
40. DAVISS SR; CONLEY RR
    DENSITY AND DISTRIBUTION OF LABELED SUBPOPULATIONS OF MEDIODORSAL THALAMIC NEURONS IN SCHIZOPHRENIC AND CONTROL SUBJECTS
    Schizophrenia research
    
    S.R. Daviss e R.R. Conley, "DENSITY AND DISTRIBUTION OF LABELED SUBPOPULATIONS OF MEDIODORSAL THALAMIC NEURONS IN SCHIZOPHRENIC AND CONTROL SUBJECTS", Schizophrenia research, 15(1-2), 1995, pp. 27-27
41. PANDEY GN; PANDEY SC; CONLEY RR; ROBERTS R; TAMMINGA CA
    BENZODIAZEPRINE RECEPTORS IN HUMAN POSTMORTEM BRAIN - EFFECT OF SCHIZOPHRENIA, SUICIDE, AND NEUROLEPTIC DRUG-TREATMENT
    Schizophrenia research
    
    G.N. Pandey et al., "BENZODIAZEPRINE RECEPTORS IN HUMAN POSTMORTEM BRAIN - EFFECT OF SCHIZOPHRENIA, SUICIDE, AND NEUROLEPTIC DRUG-TREATMENT", Schizophrenia research, 15(1-2), 1995, pp. 68-68
42. CARPENTER WT; CONLEY RR; BUCHANAN RW; BREIER A; TAMMINGA CA
    PATIENT RESPONSE AND RESOURCE-MANAGEMENT - ANOTHER VIEW OF CLOZAPINE TREATMENT OF SCHIZOPHRENIA
    The American journal of psychiatry
    
    W.T. Carpenter et al., "PATIENT RESPONSE AND RESOURCE-MANAGEMENT - ANOTHER VIEW OF CLOZAPINE TREATMENT OF SCHIZOPHRENIA", The American journal of psychiatry, 152(6), 1995, pp. 827-832
43. TAMMINGA CA; CONLEY RR; WONG DF
    HUMAN BRAIN RECEPTORS .4. HUMAN IN-VIVO RECEPTOR IMAGING
    The American journal of psychiatry
    
    C.A. Tamminga et al., "HUMAN BRAIN RECEPTORS .4. HUMAN IN-VIVO RECEPTOR IMAGING", The American journal of psychiatry, 151(5), 1994, pp. 639-639
44. HOLCOMB HH; CASCELLA NG; MEDOFF DR; GASTINEAU EA; LOATS H; THAKER GK; CONLEY RR; DANNALS RF; WAGNER HN; TAMMINGA CA
    PET-FDG TEST-RETEST RELIABILITY DURING A VISUAL-DISCRIMINATION TASK IN SCHIZOPHRENIA
    Journal of computer assisted tomography
    
    H.H. Holcomb et al., "PET-FDG TEST-RETEST RELIABILITY DURING A VISUAL-DISCRIMINATION TASK IN SCHIZOPHRENIA", Journal of computer assisted tomography, 17(5), 1993, pp. 704-709
45. CONLEY RR; GOUNARIS CJ; WONG DF; TAMMINGA CT
    CLOZAPINE VS HALOPERIDOL DOPAMINE RECEPTOR OCCUPANCY IN SCHIZOPHRENIABY C-11 NMSP PET
    Biological psychiatry
    
    R.R. Conley et al., "CLOZAPINE VS HALOPERIDOL DOPAMINE RECEPTOR OCCUPANCY IN SCHIZOPHRENIABY C-11 NMSP PET", Biological psychiatry, 33(6A), 1993, pp. 59-59
46. CONLEY RR; CARLSSON A; LAHTI A; TAMMINGA CA
    THE USE OF PRECLAMOL (-3PPP) FOR NEUROLEPTIC-INDUCED PSEUDOPARKINSONISM
    Biological psychiatry
    
    R.R. Conley et al., "THE USE OF PRECLAMOL (-3PPP) FOR NEUROLEPTIC-INDUCED PSEUDOPARKINSONISM", Biological psychiatry, 33(6A), 1993, pp. 127-127